The Spanish Agency for Medicines and Medical Devices (AEMPS) has confirmed a total of 111 cases of breast implant-associated anaplastic large cell lymphoma (ALCL) up to 2025, a rare type of cancer linked to breast implants. In all, the agency has received 146 suspected reports since it began monitoring this condition in 2012.
The figures appear in the sixth follow-up report on the national protocol for the detection and study of this type of lymphoma, drawn up on the basis of notifications recorded in the Medical Devices Surveillance System. For years now, AEMPS has been carrying out specific monitoring of this disease together with medical societies and European health authorities.
According to the report released by the agency, Madrid is the autonomous community with the highest number of reports, ahead of Andalusia, Catalonia and the Valencian Community.
A rare cancer linked to certain implants
Breast implant-associated ALCL, known internationally as BIA-ALCL, is a rare type of non-Hodgkin lymphoma that does not originate in breast tissue, but in immune system cells that can develop in the fibrous capsule of tissue surrounding the implant.
